Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine

17 Jul 2025

Abstract excerpt

Heart failure (HF) is a global health burden characterized by high morbidity and mortality, necessitating advancements in diagnostic and therapeutic approaches. Molecular diagnostics, encompassing genomics, transcriptomics, proteomics, metabolomics, and epigenetics, offer unprecedented insights into HF pathogenesis, aiding early diagnosis, risk stratification, and personalized management. This state-of-the-art...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Function and Risk Factors
Share to GDF15 and Related Biomarkers
Share to Heart Failure Treatment and Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40722556
DOI: 10.3390/diagnostics15141807

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicinePMID 40722556Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure ResearchSemantic proximity Read ↗

Omics phenotyping in heart failure: the next frontierSemantic proximity Read ↗

Drug Discovery and Development for Heart Failure Using Multi-Omics ApproachesSemantic proximity Read ↗

Is It the Time to Revolutionize the Heart Failure Management with Emerging Biomarkers and Innovative Targeted Treatments? From Re-Search Evidence to ClinicSemantic proximity Read ↗

Genetic Biomarkers in Heart Failure: From Gene Panels to Polygenic Risk Scores.Semantic proximity Read ↗

Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.Semantic proximity Read ↗

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.Semantic proximity Read ↗

Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and PerspectivesSemantic proximity Read ↗

Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection FractionSemantic proximity Read ↗

Clinical-transcriptional prioritization of the circulating proteome in human heart failureSemantic proximity Read ↗

Profiling of the plasma proteome across different stages of human heart failureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.